Welcome to the e-CCO Library!

P676: Comparison of real-world outcomes of adalimumab and infliximab for patients with ulcerative colitis in the United States
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Sandborn W.*1, Sakuraba A.2, Wang A.3, Macaulay D.4, Schemerold L.4, Yang M.5, Skup M.3

Created: Wednesday, 20 February 2019, 10:36 AM
P676: Correlation of lipid levels with reduction in inflammation in patients with ulcerative colitis: Data from the tofacitinib OCTAVE clinical trials
Year: 2018
Source: ECCO '18 Vienna
Authors:

B.G. Feagan1, C.Y. Ha2, P.R. Taub3, D. Quirk4, C.I. Nduaka4, L. Salese4, G. Chan4, G.S. Friedman4, W. Wang4, C. Su4, W. Reinisch5*

Created: Thursday, 21 February 2019, 9:14 AM
P676: Intestinal ultrasound accurately predicts therapy failure in Crohn's disease patients during a biologics-induced remission
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Albshesh, A.(1)*;Abend, A.(2); Margalit Yehuda, R.(1);Mahajna, H.(1);Ben-Horin, S.(1);Kopylov, U.(1);Carter, D.(1);
Created: Friday, 14 July 2023, 11:12 AM
P676: The impact to disease activity, iron and vitamin D deficiency on fatigue in IBD patients
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Atanassova*1, A. Georgieva1, D. Gerova2, M. Todorova2

Created: Friday, 22 February 2019, 9:41 AM
P676: The small intestinal microbiome in Crohn’s disease is characterised by increased luminal diversity and stable mucosa-associated communities
Year: 2021
Source: ECCO'21 Virtual
Authors: Wauters, L.(1,2);Tito, R.(3,4);Ceulemans, M.(2);Moens, A.(1,2);Outtier, A.(1);Sabino, J.(1,2);Ferrante, M.(1,2);Vermeire, S.(1,2);Vanuytsel, T.(1,2);Raes, J.(4,5);
Created: Wednesday, 2 June 2021, 4:12 PM
P677 It’s time to grow up: what is it like to transition from the paediatric to adult inflammatory bowel disease service?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

P. Keightley1,2, R. Prematunga1, P. Hoffmann3, K. Subramaniam2,4

Created: Thursday, 30 January 2020, 10:12 AM
P677: Azathioprine dosing and metabolite measurement in paediatric inflammatory bowel disease—does one size fit all?
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Tresman*, M. Mutalib, J. Kammermeier, R. Vora

Created: Thursday, 21 February 2019, 9:14 AM
P677: Combination of vedolizumab and exclusive enteral nutrition in patients with moderate to severe Crohn's Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kang, J.(1,2,3);Wang, J.(1,2,3);Lu, Y.(4);Li, J.(1,2,3);Su, J.(1,2,3);Ying, A.(1,2,3);Ren, H.(1,2,3);Zhou, Q.(1,2,3);Wang, Y.(1,2,3);Ding, Y.(1,2,3);An, P.(1,2,3)*;
Created: Friday, 14 July 2023, 11:12 AM
P677: Effect of late faecal loss of infliximab on treatment response of inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

F. AlborziAvanaki*1, H. Rezvan1, N. Ebrahimi Daryani1, N. Ale Taha1

Created: Friday, 22 February 2019, 9:41 AM
P677: Fungal abundance is related to inflammatory status in Ulcerative Colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Herrera De Guise, C.M.(1); Sarrabayrouse, G.(2);Varela, E.(2);Robles, V.(1);Borruel, N.(1);Mayorga, L.F.(1);Casellas, F.(1);Ibarz, A.(2);Perez, Z.(1);Robles, M.(1);Guarner, F.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P677: Impact of patient reported outcomes, coping strategies and psychosocial factors on medication adherence in inflammatory bowel disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Chao C.-Y.*1,2, Lemieux C.1, Afif W.1, Bitton A.1, Wild G.1, Bessissow T.1

Created: Wednesday, 20 February 2019, 10:36 AM
P677: Patients with Inflammatory Bowel Diseases on anti-TNF treatment have impaired antibody production after Anti-SARS-CoV-2 vaccination: Results from a Panhellenic registry
Year: 2022
Source: ECCO'22
Authors: Zacharopoulou, E.(1);Orfanoudaki, E.(2);Kitsou, V.(3);Tzouvala, M.(1);Tribonias, G.(1);Mantzaris, G.J.(4);Viazis, N.(4);Christidou, A.(4);Almpani, F.(4);Karmiris, K.(5);Theodoropoulou, A.(5);Tsafaridou, M.(2);Michopoulos, S.(6);Zampeli, E.(6);Papathanasiou, E.(6);Michalopoulos, G.(7);Tigkas, S.(7);Karatzas, P.(8);Laoudi, E.(8);Liatsos, C.(9);Kyriakos, N.(9);Mylonas, I.(9);Theocharis, G.(10);Koutroubakis, I.E.(2);Bamias, G.(3);
Created: Friday, 11 February 2022, 3:56 PM
P678 Effect of accelerated infliximab induction on short-term outcomes of paediatric acute severe ulcerative colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M.B. Coronel-Arismendi, G. Pujol Muncunill, B. Minguez-Rodríguez, S. Feo-Ortego, L.N. Guevara-Caviedes, V. Vila-Miravet, F.J. Martin De Carpi

Created: Thursday, 30 January 2020, 10:12 AM
P678: Definition of a microbial signature as a predictor of post-surgical recurrence in patients with Crohn's disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Oliver, L.(1);Amoedo, J.(1);Julià, D.(2);Camps, B.(3);Ramió-Pujol, S.(1);Malagón, M.(1);Torres, P.(4);Domènech, E.(4);Guardiola, J.(3);Serra-Pagès, M.(1);Garcia-Gil, J.(5);Aldeguer, X.(2);
Created: Wednesday, 2 June 2021, 4:12 PM
P678: Did toxicity profile of azathioprine changed within the last 10 years: comparative 17 years data from a single tertiary IBD center
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Bozcan S., Hatemi I., Yıldırım S., Demir N., Erzin Y., Celik A.F.

Created: Wednesday, 20 February 2019, 10:36 AM
P678: Rare and severe complications in paediatric Inflammatory Bowel Disease: results of 5 years of international collaboration through the PIBD-SETQuality Safety Registry
Year: 2022
Source: ECCO'22
Authors: Klomberg, R.(1);Kemos, P.(2);Chondrou, P.(2);Croft, N.(2);de Ridder, L.(1);
Created: Friday, 11 February 2022, 3:56 PM
P678: Risk of malnutrition in patients with inflammatory bowel diseases: Results from an Italian multi-centre observational cross-sectional study
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. Viganò1*, A. Losco2, I. Bergna1, G. Meucci3, A. Amato4, GSMII (Gruppo di Studio per le Malattie Infiammatorie Intestinali)

Created: Thursday, 21 February 2019, 9:14 AM
P678: Treatment of moderate to severe UC patients with new 5ASA tablets
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Laoun*1, R. Hofmann2

Created: Friday, 22 February 2019, 9:41 AM
P678: Ustekinumab therapy improves the nutritional status in patients with Crohn's Disease. A prospective study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: BertaniMD, L.(1,2)*;D'Alessandro, C.(1);Fornili, M.(3);Coppini, F.(1);Zanzi, F.(1);Carmisciano, L.(3);Geri, F.(1);Baiano Svizzero, G.(4);Ceccarelli, L.(4);Mumolo, M.G.(4);Baglietto, L.(3);Bellini, M.(1);Costa, F.(4);De Bortoli, N.(1);
Created: Friday, 14 July 2023, 11:12 AM
P679 What is the best strategy after failure to anti-TNF? Ustekinumab or other anti-TNF?
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A. Cerpa Arencibia, C. Suarez Ferrer, J. Poza Cordón, E. Martín Arranz, L. Ramírez, M.D. Martín Arranz

Created: Thursday, 30 January 2020, 10:12 AM